A leica biosystems representative from north america technical support who contacted the complainant on 09 november 2016, was advised that no action was required from leica biosystems; and the offer of support/assistance was refused.Based on the information provided by the complainant that the sub-optimal tissue processing was resolved following replacement of the "70% alcohols", it is considered possible that the interaction between the device and the user either caused or contributed to the sub-optimal tissue processing reported.As a consequence of this possible use error involving completion of the reagent replacement process, it was determined that the available information meets the regulatory agency reportability criteria because the circumstance described has previously caused a serious injury.
|
Leica biosystems received a complaint that prostate biopsy samples in six (6) cassettes, which had been processed in a protocol executed in retort b, which completed at 07:00 am, were "hard to cut." the complainant advised that a total of 82 cassettes had been processed in the affected protocol; and the tissue samples in the remaining 76 cassettes, which were gastro-intestinal biopsy samples, were not adversely affected.The complainant also advised that no complaint(s) had been received regarding the morphology of the affected samples; all specimens were diagnosable; no error(s) had been recorded during execution of the affected protocol and that: "70% alcohols were changed the problem was gone.".
|